HK1046236A1 - 迅速溶解的剂量形式及其生产方法 - Google Patents

迅速溶解的剂量形式及其生产方法 Download PDF

Info

Publication number
HK1046236A1
HK1046236A1 HK02107469.5A HK02107469A HK1046236A1 HK 1046236 A1 HK1046236 A1 HK 1046236A1 HK 02107469 A HK02107469 A HK 02107469A HK 1046236 A1 HK1046236 A1 HK 1046236A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
making same
rapidly dissolving
dissolving dosage
relates
Prior art date
Application number
HK02107469.5A
Other languages
English (en)
Chinese (zh)
Inventor
Martani Rosa
Original Assignee
Novartis Consumer Health S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health S.A. filed Critical Novartis Consumer Health S.A.
Publication of HK1046236A1 publication Critical patent/HK1046236A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02107469.5A 1999-08-17 2000-08-14 迅速溶解的剂量形式及其生产方法 HK1046236A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99810738.7 1999-08-17
EP99810738 1999-08-17
PCT/EP2000/007934 WO2001012161A1 (en) 1999-08-17 2000-08-14 Rapidly dissolving dosage form and process for making same

Publications (1)

Publication Number Publication Date
HK1046236A1 true HK1046236A1 (zh) 2003-01-03

Family

ID=8242980

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107469.5A HK1046236A1 (zh) 1999-08-17 2000-08-14 迅速溶解的剂量形式及其生产方法

Country Status (8)

Country Link
US (1) US7182959B2 (enExample)
EP (1) EP1202716A1 (enExample)
JP (1) JP2003506480A (enExample)
AU (1) AU765526B2 (enExample)
CA (1) CA2380449A1 (enExample)
HK (1) HK1046236A1 (enExample)
TR (1) TR200200313T2 (enExample)
WO (1) WO2001012161A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
ES2261726T3 (es) * 2001-08-09 2006-11-16 Smithkline Beecham Plc Composicion que comprende paroxetina y una sal glicirricinato farmaceuticamente aceptable.
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2003068604A1 (en) * 2002-02-13 2003-08-21 Weibel Michael K Drug dose-form and method of manufacture
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
JP4320217B2 (ja) * 2002-07-10 2009-08-26 剤盛堂薬品株式会社 鼻炎用経口製剤
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20050214365A1 (en) * 2004-03-24 2005-09-29 Gulf Pharmaceutical Industries [Instant dissolving tablet composition for loratidine and desloratidine]
TWI547431B (zh) * 2004-06-09 2016-09-01 史密斯克萊美占公司 生產藥物之裝置及方法
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
PE20060935A1 (es) 2004-10-21 2006-10-26 Novartis Ag Composicion farmaceutica que comprende diclofenaco
CN102631289B (zh) * 2004-10-28 2016-05-04 潘特克股份公司 高孔隙度的速崩固体剂型及其包括生产粉末和冻干步骤的制备方法
WO2008079343A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
EP2170282A4 (en) * 2007-06-27 2014-11-05 Hanmi Pharm Ind Co Ltd METHOD FOR PRODUCING A QUICKLY CRUSHING FORMULATION FOR ORAL ADMINISTRATION AND DEVICE FOR PREPARING AND PACKAGING THE FORMULATION
EP2385769A4 (en) * 2008-12-15 2014-08-20 Valeant Pharmaceuticals Luxembourg S R L QUICKLY SOLUBLE VITAMIN FORMULATION AND METHOD FOR THEIR USE
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US9968564B2 (en) * 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
WO2011022737A2 (en) * 2009-08-17 2011-02-24 Waxtabs (Pty) Ltd Tablet manufacture
CN102933207B (zh) * 2009-10-30 2018-02-02 Ix生物医药有限公司 快速溶解固体剂型
US20110105441A1 (en) * 2009-10-30 2011-05-05 Fmc Corporation Stable Orally Disintegrating Tablets Having Low Superdisintegrant
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
EP2515879A4 (en) * 2009-12-22 2014-04-02 Fmc Corp Inc FINE PARTICLE CROSCARMELLOSIS AND USES THEREOF
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
BR112012024432A2 (pt) 2010-03-29 2016-05-31 Ferring Bv composição farmacêutica de dissolução rápida
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CA2800251A1 (en) * 2010-05-25 2011-12-01 David Kossor Compositions and methods for reduction of mercury toxicity
NZ620897A (en) 2011-09-16 2016-07-29 Ferring Bv A fast dissolving pharmaceutical composition
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311490A (en) * 1980-12-22 1982-01-19 General Electric Company Diamond and cubic boron nitride abrasive compacts using size selective abrasive particle layers
ATE24964T1 (de) * 1981-12-11 1987-01-15 Wyeth John & Brother Ltd Verfahren zur herstellung von festen formgegenstaenden.
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
EP0524180B1 (en) * 1990-04-11 1995-04-26 The Upjohn Company Taste masking of ibuprofen by fluid bed coating
ATE245023T1 (de) * 1991-05-28 2003-08-15 Mcneil Ppc Inc Kaubare zusammensetzung zur arzneimittelfreisetzung
RU2109509C1 (ru) * 1991-12-24 1998-04-27 Яманути Фармасьютикал Ко., Лтд. Композиция для буккального введения лекарственного средства и способ ее получения
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
TR199802068T2 (xx) * 1996-04-16 2000-01-21 Novartis Consumer Health S.A. H�zl� b�l�nen oral doz formu.
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
JPH11116466A (ja) * 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 急速溶解型固形製剤およびその製造法
US6194395B1 (en) * 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations

Also Published As

Publication number Publication date
WO2001012161A1 (en) 2001-02-22
AU765526B2 (en) 2003-09-18
CA2380449A1 (en) 2001-02-22
US7182959B2 (en) 2007-02-27
AU7275700A (en) 2001-03-13
TR200200313T2 (tr) 2002-04-22
EP1202716A1 (en) 2002-05-08
US20020131998A1 (en) 2002-09-19
JP2003506480A (ja) 2003-02-18

Similar Documents

Publication Publication Date Title
HK1046236A1 (zh) 迅速溶解的剂量形式及其生产方法
WO1997038679A3 (en) Fast disintegrating oral dosage form
CA2301132A1 (en) Rapidly disintegrating methylcellulose tablets
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
MXPA02003596A (es) Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion.
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
IL160797A0 (en) ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17beta-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
HUP0401213A3 (en) Compounds effecting glucokinase, process for their preparation and their use for production of pharmaceutical compositions
WO2002015927A8 (en) High mannose proteins and methods of making high mannose proteins
CA2408848A1 (en) Rapidly disintegrating solid oral dosage form
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
EP1120109A3 (en) Rapidly disintegrating and fast dissolving solid dosage form
IS7126A (is) Lyfjablanda á formi sviflausnar, sem gerð hefur verið stöðug, og gefin er inn um munn
HUP0102676A2 (hu) Szilárd, gyorsan széteső cetirizint tartalmazó gyógyszerkészítmények
MXPA04005767A (es) Formacion previa para hacer tabletas de mezclas naturales de estrogenos conjugados.
WO2002047607A3 (en) Process for the preparation of a fast dissolving dosage form
WO2002094774A3 (en) Oxcarbazepine dosage forms
EP1595533A4 (en) RASCH IN THE MOUTHHOUSE MELTING TABLET
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
AU2002360958A1 (en) METHOD FOR PRODUCING Beta MANNITOL DIRECTLY COMPRESSIBLE INTO TABLETS
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
CA2429639A1 (en) Stable azithromycin monohydrate
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
DK1227797T3 (da) Farmaceutiske faststofdispersionsformuleringer
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers